Equities

Certara Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Certara Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.94
  • Today's Change-0.41 / -5.58%
  • Shares traded1.63m
  • 1 Year change-41.73%
  • Beta1.5661
Data delayed at least 15 minutes, as of Mar 05 2026 18:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Certara Inc grew revenues 8.75% from 385.15m to 418.84m while net income improved from a loss of 12.05m to a smaller loss of 1.60m.
Gross margin61.53%
Net profit margin-0.38%
Operating margin5.02%
Return on assets-0.10%
Return on equity-0.15%
Return on investment-0.11%
More ▼

Cash flow in USDView more

In 2025, Certara Inc increased its cash reserves by 5.70%, or 10.21m. The company earned 96.33m from its operations for a Cash Flow Margin of 23.00%. In addition the company used 26.56m on investing activities and also paid 63.99m in financing cash flows.
Cash flow per share0.4583
Price/Cash flow per share15.90
Book value per share6.68
Tangible book value per share-0.9928
More ▼

Balance sheet in USDView more

Certara Inc has a Debt to Total Capital ratio of 21.62%, a lower figure than the previous year's 27.62%.
Current ratio2.05
Quick ratio--
Total debt/total equity0.2758
Total debt/total capital0.2162
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.